Navigation Links
Amilpar Acquires ESHO

RIO DE JANEIRO, Feb. 1 /PRNewswire-FirstCall/ -- Amil Participacoes S.A. (Bovespa: AMIL3) ("Amilpar"), in accordance with CVM (the Brazilian Securities and Exchange Commission) Instruction 358/02, informs that today it exercised the option to purchase 100% of ESHO - Empresa de Servicos Hospitalares Ltda, as established in the Management and Hospital Call Option Agreement, signed on October 18, 2007, in the total amount of R$ 60.1 million, set after the auditing process, according to the decision taken by Amilpar's Board of Directors, in a meeting held on November 9, 2009.

The payment will be made in 48 monthly and successive installments, adjusted by the CDI (average interbank deposit rate in Brazil), the first installment with maturity on February 18 and the other installments on the 15th day of each month.

The main assets that comprise ESHO are the three hospitals which were already managed by Amilpar, as established in the Management and Hospital Call Option Agreement, and this acquisition is the accomplishment of the compromise made by Amilpar at the time of its IPO. Hospital information:

(i) CardioTrauma Hospital, located at Rua Farme de Amoedo, Ipanema, in the city and state of Rio de Janeiro, has 46 beds;

(ii) Mario Lioni Hospital, located at Rua Ana Neri, Bairro Vinte e Cinco de Agosto, Duque de Caxias, in the state of Rio de Janeiro, has 120 beds;

(iii) Hospital Paulistano, located at Rua Martiniano de Carvalho, the corner with Rua Pio XII, Bairro Liberdade, in the city and state of Sao Paulo, has 211 beds.

    To access the press release, visit our website at

    IR Contact
    Erwin Kleuser
    Investor Relations Officer
    Phone: +55 (21) 3805-1155

SOURCE Amil Participacoes S.A.



SOURCE Amil Participacoes S.A.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Amilpar - Relevant Fact - Public Offer Result
2. Amilpar - Press Release
3. Amilpar - Distribution of Interest on Capital Stock
4. Amilpar - Relevant Fact
5. Amilpar - Press Release - Commercial Papers
6. Amilpar - Relevant Fact - Public Offer
7. Amilpar - Revenues Grow 8% and Net Income Improves 28% in 3Q09
8. Amilpar - Operating Revenues Grew 9% in the Second Quarter and 11% in the First Half of 2009
9. Amilpar - Revenue Increases 13.4% and Medical Loss Ratio Falls in the First Quarter 2009
10. Amilpar - Revenues Increase by 26.5% and Adjusted Net Income Climbs 28.7% in 2008
11. Amilpar - Notice to Shareholders - Distribution of Interest on Capital Stock
Post Your Comments:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Lori R. ... a member of ElderCounsel, a national organization of elder law and special needs planning ... laws and rules. It also provides a forum to network with elder law attorneys ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids ... Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, ... run is geared towards children of all ages; it is a non-competitive, non-timed event, ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... ... , ... IsoComforter, Inc. ( ), one of the Nation’s ... design of the shoulder pad. The shoulder pad provides optimal support and full ... while using cold therapy. By utilizing ice and water that is circulated from an ...
(Date:10/12/2017)... , ... October 12, 2017 , ... HMP , ... recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ ... on October 11, 2017. , The annual award competition recognizes editorial and design excellence ...
Breaking Medicine News(10 mins):
(Date:9/19/2017)... 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically ... announced three leadership team developments today:   ... ... Tom ... Veteran medical device executive Josh Stopek , PhD, who ...
(Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
(Date:9/12/2017)...  Consumer reviews on the independent review site Consumer Affairs ... company for hearing aids, ranking it higher than Miracle Ear ... ... For Hearing Aids ... online store that provides high performance, state-of-the-art, German-engineered hearing aids directly ...
Breaking Medicine Technology: